loader

AbbVie Inc.

NYSE:ABBV:US
Featured Articles and Interviews

Alzheimer’s Disease Treatment Stocks: 3 Biggest NASDAQ Companies

5 Biggest Pharmaceutical ETFs in 2025

What is In-Licensing?

Press Releases

AbbVie Declares Quarterly Dividend

AbbVie Announces New Data Demonstrating Atogepant Achieves Superiority Across All Endpoints in Phase 3 Head-to-Head Study Compared to Topiramate for Migraine Prevention

AbbVie Provides Update on VERONA Trial for Newly Diagnosed Higher-Risk Myelodysplastic Syndromes

AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Interactive Chart

×